Federal Pradaxa Bleed Lawsuits Consolidated to Single Judge in Illinois

Aug. 8, 2012 - PRLog -- On August 8, 2012, the Judicial Panel on Multidistrict Litigation ordered the transfer and consolidation of all federal Pradaxa lawsuits involving Pradaxa bleeds to the U.S. District Court for the Southern District of Illinois before Judge David Herndon. [1]

Pradaxa is a direct thrombin inhibitor used to reduce the risk of stroke and embolism in patients with non-valvular atrial fibrillation.  The Order already transferred 21 pending lawsuits wherein plaintiffs allege Pradaxa caused uncontrolled/excessive bleeding and that the drug’s manufacturer failed to warn physicians that there weren’t any effective reversal agents.

Approximately 275,000 Pradaxa prescriptions were written from October 2010 to March 2011, according to HarrisMartin. [2] In that time period, the U.S. Food and Drug Administration (FDA) received 932 reports of serious adverse events associated with the use of the drug, including 500 severe bleeds and 120 deaths.

On October 6, 2011, the Institute for Safe Medication Practices, (ISMP), reported that Pradaxa moved to near the top of their adverse event rankings, with more reports than 98.7% of the drugs it regularly monitors. [3] ISMP’s report discusses the hemorrhages associated with Pradaxa, as well as the rapid launch of the medication, thereby resulting in hundreds of adverse events reports within weeks of approval.  Finally, on December 7, 2011, the U. S. Food and Drug Administration (FDA) issued a Safety Communication reporting that it was investigating reports of serious and fatal bleeds in patients taking Pradaxa. [4]

Ennis & Ennis has been investigating these claims since December 2011 and continues to offer free, nationwide, confidential consultations to anyone who has suffered a serious bleed, such as a brain bleed or a gastrointestinal bleed, while or shortly after taking Pradaxa, by calling toll free 1-800-856-6405 or by going to www.ennislaw.com and completing an online case evaluation form.

Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. that concentrates its practice in mass torts, representing individuals against pharmaceutical companies as well as medical device makers.

Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $100 million in settlements for its clients.

Ennis & Ennis, P.A. is also investigating cases involving Actos, Fosamax, Plavix, Paxil, Zoloft, Prozac, Depuy Hip Recall, Wright Conserve Hip Devices, Wright Profemur Hip Devices, Zimmer Hip Recall, any metal-on-metal hip implants, Reglan, SJS/Dilantin, Medtronic Infuse Bone Graft, Granuflo and Naturalyte Dialysis, Yaz, Yasmin, Ocella Birth Control Pills, and Transvaginal Mesh Devices.

Remember the law limits the time in which you can file a claim, so don't wait to explore your legal rights.  Call today toll free 1-800-856-6405 or visit www.ennislaw.com.


[1]. http://www.ennislaw.com/Pradaxa-Transfer-Order.pdf
[2].  http://www.Harrismartin.com
[3]. http://www.ismp.org/quarterwatch/pdfs/2010Q4.pdf
[4]. http://www.fda.gov/Drugs/DrugSafety/ucm282724.htm